El funcionamiento adecuado de un sistema de estimulación cardiaca depende de una indicación, modo de estimulación y seguimiento correctos. El seguimiento debe seguir un protocolo que incluya personal especializado, test de umbral de estimulación y detección, análisis de batería, electrodos y arritmias, con una periodicidad determinada, directamente con el paciente y/o por contactos telemétricos desde el domicilio del paciente. En segundo lugar, se analizan los problemas objetivados tanto en estimulación como en detección en cada una de las cámaras cardiacas. Por último, se lleva a cabo una actualización del síndrome de marcapasos.
Palabras clave
Marcapasos
Seguimiento
Monitorización remota
Síndrome de marcapasos
Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
R. Coma-Samartín, R. García-Calabozo, J. Martínez-Ferrer, M.J. Sancho Tello-de Carranza, F. Ruiz-Mateas.
Registro español de marcapasos. III Informe oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2005).
Rev Esp Cardiol, (2006), 59 pp. 303-313
[2.]
J. De Juan Montiel.
Novedades en estimulación cardiaca.
Rev Esp Cardiol Supl, (2004), 4 pp. A55-A65
[3.]
R. García Calabozo, J. Martínez Ferrer, M.J. Sancho-Tello de Carranza.
Temas de actualidad en estimulación cardiaca 2005.
Rev Esp Cardiol, (2006), 59 pp. 66-77
[4.]
I. Fernández-Lozano, J. Brugada-Terradellas, J. Belaza.
Resincronización en España. Implantes por habitante: datos comparativos.
Rev Esp Cardiol Supl, (2005), 5 pp. B12-B17
[5.]
G. Gregoratos, J. Abrams, A.E. Epstein, R.A. Freeman, D.L. Hayes, M.A. Hlatky, et al.
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices.
Circulation, (2002), 106 pp. 2145-2161
[6.]
R. Oter-Rodríguez, J. De Juan-Montiel, T. Roldán-Pascual, A. Barda jí-Ruiz, E. Molinero-de Miguel.
Guías de práctica clínica de la Sociedad Española de Cardiología.
Rev Esp Cardiol, (2000), 53 pp. 947-966
[7.]
P.R. Roberts.
Follow up and optimisation of cardiac pacing.
Heart, (2005), 91 pp. 1229-1234
[8.]
M.H. Schoenfeld.
Contemporary pacemaker and defibrillator device theraphy. Challenges confronting the general cardiologist.
Cir culation, (2007), 115 pp. 638-653
[9.]
R. García-Calabozo, A. Goicolea de Oro, A. Hernández Madrid, D. Lorente Carreño, J. Martínez Ferrer, J. Roda Nicolás.
Guía del paciente portador de marcapasos.
2.ª ed., Sección de Estimulación Cardiaca. Sociedad Española de Cardiología, (2002),
[10.]
M.A. Word, K.A. Ellenbogen.
Cardiac pacemakers from the pa tient's perspective.
Circulation, (2002), 105 pp. 2136-2138
[11.]
J. De Juan Montiel, A. Bardají, J. Vañó, R. Toda, T. Benet, C. Ridao.
Control y seguimiento de los pacientes portadores de marcapasos unicamerales en consulta ambulatoria.
Rev Esp Cardiol, (1990), 43 pp. 32-39
[12.]
M.H. Schoenfeld, M.L. Blitzer.
Follow-up assessments of the pace maker patient. Chapter 11.
Cardiac Pacing and ICDs, 4.ª ed., Blackwell Publishing, pp. 500-543
[13.]
R. Pavón, M. Sitges.
Nuevos retos en la optimización de los dispositivos de resincronización.
Rev Esp Cardiol, (2005), 5 pp. B28-34
[14.]
E. Díaz-Infante, A. Hernández-Madrid, J. Brugada-Terradellas, I. Fernández-Lozano, I. García Bolao, J. Leal del Ojo, et al.
Con senso sobre la terapia de resincronización cardiaca.
Rev Esp Cardiol Supl, (2005), 5 pp. B3-B11
[15.]
M.H. Schoenfeld, H.T. Markowitz.
Device follow-up in the age of automaticity.
PACE, (2000), 23 pp. 803-806
[16.]
H. Grendahl.
Pacemaker follow-up with prolonged intervals in the stable period 1 to 5 years post-implanted.
PACE, (1996), 19 pp. 1219-1224
[17.]
L. Padeletti, S. Barold.
Digital technology for cardiac pacing.
Am J Cardiol, (2005), 95 pp. 479-482
[18.]
S.C. Vlay.
Advances in telemetry of implanted devices: new opportunities- New responsibilities.
PACE, (2006), 29 pp. 557-558
[19.]
A. Lazarus.
Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
PACE, (2007), 30 pp. S2-S12
[20.]
G. Calcagnini, F. Censi, M. Floris, C. Pignalberi, R. Ricci, G. Biancalana, et al.
Evaluation of electromagnetic interference of GSM mobile phones with pacemakers featuring remote monitoring functions.
PACE, (2006), 29 pp. 380-385
[21.]
K. Breivik, H. Engedal, O. Ohm.
Electrophysiological properties of a new permanent endocardial lead for uni- or bipolar pacing.
PACE, (1968), 5 pp. 268-274
[22.]
J. Olagüe, M.J. Sancho-Tello, A. Chirivella, J.L. Díez, J. Bonastre, J.E. Castro, et al.
Prolongation of expected life of the batteries with unipolar configuration of pacing in ambipolar pacemakers.
Proceedings of Xth World Symposium on Cardiac Pacing and Electrophysiology, (1995),
[23.]
S. Botella Solana, J. Olagüe, L. Insa.
Control de marcapasos. Automatismo y conducción cardíacos, Institución Alfonso el Magnáni mo, pp. 663-686
[24.]
A.D. Bramowitz, J.W. Smith, L.M. Eber, S.C. Berens, M. Bilitch, M. Grechko, et al.
Runaway pacemaker: A persisting problem.
J Am Med Assoc, (1974), 228 pp. 340-341
[25.]
M. Bertholet, P. Materne, C. Dubois, P. Marcelle, J. Beckers, J.C. Demoulin, et al.
Artificial circus movement tachycardia: Incidence, mechanisms and prevention.
Pacing and Clin Electrophysiol, (1985), 8 pp. 415-422
[26.]
G.N. Kay, K.E. Ellenbogen.
Sensig.
Clinical Cardiac Pacing, WB Saunders Company, pp. 38-68
[27.]
M.S. Chandra, M.R. Patel, D.E. Lauqhlin, N.P. Rossi.
“False inhibition” of demand pacemaker due to leakage of fluid into the pacemaker lead socket.
J Thor Cardiovasc Surg, (1978), 75 pp. 765-768
[28.]
W.D. Widmann, J.K. Eroga, L. Thomas, P. Palmer, S. Muccione.
Inhibition of programmable pacemaker by pacemaker-induced myopotentials.
Chest, (1981), 80 pp. 328-331
[29.]
S. Amikam, H. Peleg, J. lemer, E. Riss.
Myopotential inhibition of bipolar pacemaker caused by electrode insulation defect.
Br Heart J, (1977), 39 pp. 1279-1281
[30.]
S.S. Barold, L.S. Ong, M.D. Falkoff, R.A. Heinle.
Inhibition of bipolar demand pacemaker by diaphragmatic myopotentials.
Circulation, (1977), 56 pp. 679-683
[31.]
M. El Gamal, B. Van Gelder.
Suppression o fan external demand pacemaker by diaphragmatic myopotentials: a sign of electrode perforation?.
PACE, (1979), 2 pp. 191-195
[32.]
M.B. Waxman, N.D. Berman, G. Sanz, E. Downar, P. Mendler, K.W. Taylor.
Demand pacemaker malfunction due to abnormal sensing. Report of two cases.
Circulation, (1974), 50 pp. 389-394
[33.]
A. Wirtzfeld, M. Lampadius, E.O. Ruprecht.
Inhibition of demand pacemakers by muscle potentials.
Dtsch Med Wochenschr, (1972), 97 pp. 61-66
[34.]
M. Kinderman, G. Frohling, M. Berg, P. Lawall, H. Schieffer.
Atrial lead implantation during atrial flutter o fibrillation?.
PACE, (1998), 21 pp. 1531-1538
[35.]
J. Brandt, T. Fahraeus, H. Schuller.
Far-field QRS complex sensing via the atrial pacemaker lead. II. Prevalence, clinical significance and possibility of intraoperative prediction in DDD pacing.
PACE, (1988), 11 pp. 1540-1544
[36.]
J. Brouwer, D. Nagelkerke, P. Den Heijer, J.H. Ruiter, H. Mulder, M.J. Begemann, et al.
Analysis of atrial sensed far-field ventricular signals: A reassessment.
PACE, (1997), 20 pp. 916-922
[37.]
Levine PA, Klein MD. Discrepant electrocardiographic and pulse analyzer endocardial potentials, a possible source of pacemaker sensing failure. En: Meere C, editor. Proceeding of the Sixth World Symposium on Cardiac Pacing. Montreal; January 1979, Chap. 34. p. 40-6.
[38.]
J. Kuzniec, G. Golovchiner, A. Mazur, A. Battler, B. Strasberg.
Atrial signal Amplitude measurements in VDD systems accor ding to body position.
PACE, (2004), 27 pp. 1344-1346
[39.]
J. Silny.
The interference of electronic implants in low frequency electromagnetic fields.
Arch Mal Coeur Vaiss, (2003), 96 pp. 30-34
[40.]
G. Das, J. Eaton.
Pacemaker malfunction following transthoracic countershock.
PACE, (1981), 4 pp. 487-490
[41.]
G. Altamura, L. Bianconi, F. Lo Bianco, S. Toscazo, F. Ammirati, C. Pandozi, et al.
Transthoracic DC show may represent a serious hazard in pacemaker dependent patients.
PACE, (1995), 18 pp. 194-198
[42.]
C. Waller, F. Callies, H. Langenfeld.
Adverse effects of direct current cardioversión on cardiac pacemakers and electrodes. Is external cardioversión contraindicated in patients with permanent pacing systems?.
Europace, (2004), 6 pp. 165-168
[43.]
E. Solow, B. Bacharach.
Runaway pacemaker. Unpredictable pacemaker failure.
Arch Intern Med, (1979), 139 pp. 1190-1191
[44.]
J. Pindado, J.A. Cabrera, J. Farré.
Fenómeno de runaway, una disfunción de marcapasos no resuelta.
Rev Esp Cardiol, (2005), 58 pp. 1130-1133
[45.]
D.F. Ortega, M.V. Sammartino, G.M.M. Pellegrino, L.C. Barja, G. Albina, E.V. Segura, et al.
Runaway pacemaker: A forgotten phenomenon?.
Europace, (2005), 7 pp. 592-597
[46.]
E. Oguz, A. Ahmet, E. Okmen.
Inhibition of biventricular pacing by far-field left atrial activity sensing: Case report.
PACE, (2002), 25 pp. 1517-1519
[47.]
D. Vollmann, L. Lüthje, G. Görtler, C. Unterberg.
Inhibition of bradycardia pacing and detection of ventricular fibrillation due to farfield atrial sensing in a triple-chamber ICD.
PACE, (2002), 25 pp. 1513-1516
[48.]
T. Mitsui, M. Hori, K. Suma, Y. Wanibuchi, M. Saigusi.
The “pacemaking syndrome”.
Proceedings of the eighth Annual Internacional Conference on Medical and Biologi cal Engineering, Association for the Advancement of Medical Instrumentation, pp. 29-33
[49.]
H. Schuller, J. Brandt.
The pacemaker syndrome: old and new causes.
Clin Cardiol, (1991), 14 pp. 336-344
[50.]
J. Mukharji, R.B. Rehr, A. Hastillo, J.A. Thompson, M.L. Hess, W.J. Paulsen, et al.
Comparison of atrial contribution to cardiac hemodynamics in patients with normal and severely compromised cardiac function.
Clin Cardiol, (1990), 13 pp. 639-643
[51.]
M.J. Reiter, M.C. Hindman.
Hemodynamic effects of acute atrioventricular sequential pacing in patients with left ventricular dysfunction.
Am J Cardiol, (1982), 49 pp. 687-692
[52.]
M.J. O’Connor Allen, C.E. Arentzen, R.W. Anderson, M.S. Visner, J. Fetter, D.G. Benditt.
Contribution of atrioventricular synchrony to left ventricular systolic function in a closed-chest canine model of complete heart block: implications for single-chamber rate-variable cardiac pacing.
Pacing Clin Electrophysiol, (1988), 11 pp. 404-412
[53.]
M. Akhtar, A.N. Damato, W.P. Batsford, J.N. Ruskin, J.B. Ogunkelu.
A comparative analysis of antegrade and retrograde conduction patterns in man.
Circulation, (1975), 52 pp. 766-778
[54.]
H. Tanaka, H. Katanazako, N. Uemura, Y. Toyama, T. Kanehisa.
Ventriculoatrial conduction in complete atrioventricular block due to AH block.
Jpn Heart J, (1974), 15 pp. 1-15
[55.]
K.A. Ellenbogen, M.D. Thames, P.K. Mohanty.
New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing.
Am J Cardiol, (1990), 65 pp. 53-59
[56.]
K.G. Oldroyd, A.P. Rae, R. Carter, C. Wingate, S.M. Cobbe.
Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroen ocrine variables, exercise performance, and symptoms in complete heart block.
Br Heart J, (1991), 65 pp. 188-193
[58.]
D. Heldman, D. Mulvihill, H. Nguyen, J.C. Messenger, A. Rylaarsdam, K. Evans, et al.
True incidence of pacemaker syndrome.
Pacing Clin Electrophysiol, (1990), 13 pp. 1742-1750
[59.]
M.R. Pitney, C.D. May, M.J. Davis.
Undesirable mode switching with a dual chamber rate responsive pacemaker.
Pacing Clin Electrophysiol, (1993), 16 pp. 729-737
[60.]
K. Den Dulk, F.W. Lindemans, P. Brugada, J.L. Smeets, H.J. Wellens.
Pacemaker syndrome with AAI rate variable pacing: importance of atrioventricular conduction properties, medication, and pacemaker programmability.
Pacing Clin Electrophysiol, (1988), 11 pp. 1226-1233
[61.]
J.C. Crick.
European multicenter prospective follow-up study of 1,002 implants of a single lead VDD pacing system. The European Multicenter Study Group.
Pacing Clin Electrophysiol, (1991), 14 pp. 1742-1744
Copyright ©
2007. Sociedad Española de Cardiología